Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.
Patient self-management (PSM) of oral anticoagulation is under discussion, because evidence from real-life settings is missing. Using data from a nationwide, prospective cohort study in Switzerland, we assessed overall long-term efficacy and safety of PSM and examined subgroups. Data of 1140 patient...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/20b94a5e984f4fc68374b4ddc155efe0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:20b94a5e984f4fc68374b4ddc155efe0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:20b94a5e984f4fc68374b4ddc155efe02021-11-18T08:22:26ZPatient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.1932-620310.1371/journal.pone.0095761https://doaj.org/article/20b94a5e984f4fc68374b4ddc155efe02014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24748062/?tool=EBIhttps://doaj.org/toc/1932-6203Patient self-management (PSM) of oral anticoagulation is under discussion, because evidence from real-life settings is missing. Using data from a nationwide, prospective cohort study in Switzerland, we assessed overall long-term efficacy and safety of PSM and examined subgroups. Data of 1140 patients (5818.9 patient-years) were analysed and no patient were lost to follow-up. Median follow-up was 4.3 years (range 0.2-12.8 years). Median age at the time of training was 54.2 years (range 18.2-85.2) and 34.6% were women. All-cause mortality was 1.4 per 100 patient-years (95% CI 1.1-1.7) with a higher rate in patients with atrial fibrillation (2.5; 1.6-3.7; p<0.001), patients>50 years of age (2.0; 1.6-2.6; p<0.001), and men (1.6; 1.2-2.1; p = 0.036). The rate of thromboembolic events was 0.4 (0.2-0.6) and independent from indications, sex and age. Major bleeding were observed in 1.1 (0.9-1.5) per 100 patient-years. Efficacy was comparable to standard care and new oral anticoagulants in a network meta-analysis. PSM of properly trained patients is effective and safe in a long-term real-life setting and robust across clinical subgroups. Adoption in various clinical settings, including those with limited access to medical care or rural areas is warranted.Michael NaglerLucas M BachmannPirmin SchmidPascale Raddatz MüllerWalter A WuilleminPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 4, p e95761 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Michael Nagler Lucas M Bachmann Pirmin Schmid Pascale Raddatz Müller Walter A Wuillemin Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. |
description |
Patient self-management (PSM) of oral anticoagulation is under discussion, because evidence from real-life settings is missing. Using data from a nationwide, prospective cohort study in Switzerland, we assessed overall long-term efficacy and safety of PSM and examined subgroups. Data of 1140 patients (5818.9 patient-years) were analysed and no patient were lost to follow-up. Median follow-up was 4.3 years (range 0.2-12.8 years). Median age at the time of training was 54.2 years (range 18.2-85.2) and 34.6% were women. All-cause mortality was 1.4 per 100 patient-years (95% CI 1.1-1.7) with a higher rate in patients with atrial fibrillation (2.5; 1.6-3.7; p<0.001), patients>50 years of age (2.0; 1.6-2.6; p<0.001), and men (1.6; 1.2-2.1; p = 0.036). The rate of thromboembolic events was 0.4 (0.2-0.6) and independent from indications, sex and age. Major bleeding were observed in 1.1 (0.9-1.5) per 100 patient-years. Efficacy was comparable to standard care and new oral anticoagulants in a network meta-analysis. PSM of properly trained patients is effective and safe in a long-term real-life setting and robust across clinical subgroups. Adoption in various clinical settings, including those with limited access to medical care or rural areas is warranted. |
format |
article |
author |
Michael Nagler Lucas M Bachmann Pirmin Schmid Pascale Raddatz Müller Walter A Wuillemin |
author_facet |
Michael Nagler Lucas M Bachmann Pirmin Schmid Pascale Raddatz Müller Walter A Wuillemin |
author_sort |
Michael Nagler |
title |
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. |
title_short |
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. |
title_full |
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. |
title_fullStr |
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. |
title_full_unstemmed |
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. |
title_sort |
patient self-management of oral anticoagulation with vitamin k antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/20b94a5e984f4fc68374b4ddc155efe0 |
work_keys_str_mv |
AT michaelnagler patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy AT lucasmbachmann patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy AT pirminschmid patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy AT pascaleraddatzmuller patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy AT walterawuillemin patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy |
_version_ |
1718421847593189376 |